Lixisenatide

GLP-1 Receptor Agonist

Brands

Adlyxin
Soliqua

Lixisenatide Pen Injector

DosageBrandImage
3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen InjectorGeneric
3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]Generic
3 ML lixisenatide 0.05 MG/ML Pen InjectorGeneric
3 ML lixisenatide 0.05 MG/ML Pen Injector [Adlyxin]Generic
3 ML lixisenatide 0.1 MG/ML Pen InjectorGeneric
3 ML lixisenatide 0.1 MG/ML Pen Injector [Adlyxin]Generic

Lixisenatide desired effects:

  • Decreased Glucagon Secretion
  • Decreased Gastric Motility
  • Increased Insulin Secretion

Lixisenatide drug classes:

  • GLP-1 Receptor Agonist

Lixisenatide pharmacologic actions:

  • Hypoglycemic Agents

Lixisenatide mechanism of action:

  • Glucagon-like Peptide-1 (GLP-1) Agonists
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Questions? Call or text: 859-651-7603

LegitScript approved
Copyright © Treatable 2023
Last updated: 2/11/2025, 8:22:19 PM